Whack, whack whack: it's my winter almanac
Goodbye 2022 … uh oh, here comes 2023
As Moderna announces near-95% efficacy in its new Covid-19 vaccine trial, the focus on distribution has become even more intense.
The latest vaccine from the US company could be ready to ship next year, with Moderna saying it hopes to make 500 million to 1 billion doses in 2021.
It will be easier to distribute than the Pfizer version, as Moderna claims it is more stable, can be kept at between 2C and 8C for up to 30 days and can be stored for six months at -20C. Pfizer’s vaccine requires ultracold freezing at between -70C and -80C.
The Logistics & Supply Chain Management Society and IDC have written a research paper advocating the use of a Vaccine Distribution Ecosystem in a public-private partnership that “orchestrates the private and public networks to ensure that populations are effectively inoculated”.
'Mass-casualty incident' as Maersk box ship destroys Baltimore bridge
Shock for CMA CGM as a deputy CEO decides to quit
Diversions from Red Sea proving a real ‘silver lining’ for carriers
Asia-Europe carriers revise FAK rates in fight to rein in revenue erosion
Could the Dali have suffered a power loss before bridge crash?
Strike paralysing Finnish ports extended after talks collapse
Indian Customs to auction uncleared export boxes at Nhava Sheva
Alex Lennane
email: [email protected]
mobile: +44 7879 334 389
During August 2023, please contact
Alex Whiteman
email: [email protected]
Alessandro Pasetti
email: [email protected]
mobile: +44 7402 255 512
Comment on this article